RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Recent studies showed that specific isoprenoid modification may be critical for RhoB subcellular location and function. Therefore, we determined whether the function of the highly related RhoA protein is also critically dependent on specific isoprenoid modification: (a) in contrast to observations with RhoB or Ras proteins, where farnesylated and geranylgeranylated versions showed differences in subcellular location, both prenylated versions of RhoA showed the same plasma membrane and cytosolic location; (b) a farnesylated version of activated RhoA(63L) retained the same diverse functions as the normally geranylgeranylated RhoA(63L) protein, and both proteins show indistinguishable abilities to stimulate gene expression, cause growth transformation of NIH 3T3 mouse fibroblasts, to stimulate the motility of T47D human breast epithelial cells, and to block HIV-1 viral replication and gene expression; and (c) cells expressing farnesylated RhoA retained sensitivity to the growth inhibition caused by inhibition of geranylgeranyltransferase I, indicating that other proteins are critical targets for inhibitors of geranylgeranylation.

[1]  H. Mellor,et al.  The novel Rho-family GTPase Rif regulates coordinated actin-based membrane rearrangements , 2000, Current Biology.

[2]  C. Myung,et al.  Role of Isoprenoid Lipids on the Heterotrimeric G Protein γ Subunit in Determining Effector Activation* , 1999, The Journal of Biological Chemistry.

[3]  Y. Fukada,et al.  Specific isoprenyl group linked to transducin gamma-subunit is a determinant of its unique signaling properties among G-proteins. , 1998, Biochemistry.

[4]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.

[5]  S. Sebti,et al.  Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts , 1998, Oncogene.

[6]  M. Emerman,et al.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.

[7]  C. Der,et al.  Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K , 1997, Nature.

[8]  C J Marshall,et al.  Post-translational modifications of p21rho proteins. , 1992, The Journal of biological chemistry.

[9]  P. Adamson,et al.  Intracellular localization of the P21rho proteins , 1992, The Journal of cell biology.

[10]  S. Sebti,et al.  Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice* , 2000, The Journal of Biological Chemistry.

[11]  P. Casey,et al.  Farnesyltransferase Inhibitors Alter the Prenylation and Growth-stimulating Function of RhoB* , 1997, The Journal of Biological Chemistry.

[12]  G. Prendergast,et al.  Critical role of Rho in cell transformation by oncogenic Ras. , 1995, Oncogene.

[13]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[14]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[15]  C. Der,et al.  Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes (*) , 1995, The Journal of Biological Chemistry.

[16]  G. Favre,et al.  RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Sakai,et al.  ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. , 1993, Oncogene.

[18]  S. Sebti,et al.  The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G0/G1 and Induces p21WAF1/CIP1/SDI1 in a p53-independent Manner* , 1997, The Journal of Biological Chemistry.

[19]  C. Der,et al.  Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF , 1999, Current Biology.

[20]  G. Prendergast,et al.  Prenylation of RhoB Is Required for Its Cell Transforming Function but Not Its Ability to Activate Serum Response Element-dependent Transcription* , 1997, The Journal of Biological Chemistry.

[21]  J. Gibbs,et al.  The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. , 1997, Annual review of pharmacology and toxicology.

[22]  C. Der,et al.  Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? , 1997, Biochimica et biophysica acta.

[23]  J. Settleman,et al.  Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation , 1996, Molecular and cellular biology.

[24]  F. McCormick,et al.  An essential role for Rac in Ras transformation , 1995, Nature.

[25]  D. Noh,et al.  Molecular cloning and sequencing of rat Cdc42 GTPase cDNA , 2000, Experimental & Molecular Medicine.

[26]  C. Der,et al.  Farnesyltransferase and Geranylgeranyltransferase Inhibitors , 2000 .

[27]  C. Der,et al.  Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein , 1992, Molecular and cellular biology.

[28]  V. Ferrans,et al.  rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation , 1996, Molecular and cellular biology.

[29]  C. Der,et al.  Modulation of HIV-1 Replication by a Novel RhoA Effector Activity1 , 2000, The Journal of Immunology.

[30]  S. Sebti,et al.  Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. , 1997, Pharmacology & therapeutics.

[31]  S. Merajver,et al.  RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. , 2000, Cancer research.

[32]  S. Sebti,et al.  GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. , 1997, Cancer research.

[33]  G. Prendergast,et al.  Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB , 1999, Molecular and Cellular Biology.

[34]  C. Der,et al.  Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.

[35]  C J Marshall,et al.  A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. , 1991, The EMBO journal.

[36]  C. Der,et al.  Analyses of transforming activity of Rho family activators. , 2000, Methods in enzymology.

[37]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[38]  P. Scambler,et al.  RhoE Regulates Actin Cytoskeleton Organization and Cell Migration , 1998, Molecular and Cellular Biology.

[39]  C. Hauser,et al.  Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. , 1994, Oncogene.

[40]  P. Adamson,et al.  Intracellular Localization of the P 2 lrh ~ Proteins , 1992 .

[41]  T. Jessell,et al.  RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors , 2000, Molecular and Cellular Biology.

[42]  John G. Collard,et al.  A role for Rac in Tiaml-induced membrane ruffling and invasion , 1995, Nature.

[43]  Channing J Der,et al.  Rho family proteins and Ras transformation: the RHOad less traveled gets congested , 1998, Oncogene.

[44]  David Michaelson,et al.  Differential Localization of Rho Gtpases in Live Cells , 2001, The Journal of cell biology.

[45]  M. Mattei,et al.  A New Member of the Rho Family, Rnd1, Promotes Disassembly of Actin Filament Structures and Loss of Cell Adhesion , 1998, The Journal of cell biology.

[46]  S. Sebti,et al.  Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. , 1996, Oncogene.

[47]  R. Bravo,et al.  Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. , 1997, Genes & development.

[48]  P. Fort,et al.  Characterization of TCL, a New GTPase of the Rho Family related to TC10 and Cdc42* 210 , 2000, The Journal of Biological Chemistry.

[49]  P. Casey,et al.  Lipid modifications of G proteins. , 1994, Current opinion in cell biology.

[50]  C. Cepko,et al.  Construction and applications of a highly transmissible murine retrovirus shuttle vector , 1984, Cell.

[51]  S. Sebti,et al.  RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription* , 2000, The Journal of Biological Chemistry.

[52]  C. Der,et al.  Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways , 1997, Molecular and cellular biology.

[53]  L. Van Aelst,et al.  Rho GTPases and signaling networks. , 1997, Genes & development.

[54]  R. Treisman,et al.  The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.

[55]  M. Karin,et al.  Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.

[56]  P. Keely.  Ras and Rho protein induction of motility and invasion in T47D breast adenocarcinoma cells. , 2001, Methods in enzymology.

[57]  G. Prendergast,et al.  Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity , 1995, Molecular and cellular biology.

[58]  A. Ashworth,et al.  An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 , 1995, Science.

[59]  P. Casey,et al.  Protein Prenyltransferases (*) , 1996, The Journal of Biological Chemistry.

[60]  F. McCormick,et al.  A role for Rho in Ras transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Der,et al.  Protein prenylation: more than just glue? , 1992, Current opinion in cell biology.

[62]  N. Landau,et al.  Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor , 1995, Journal of virology.